Inexpensive wearable technology for diagnostics and monitoring has the power to transform cardiac care Peerbridge Health has announced the launch of its landmark COR-INSIGHT Trial, which
Peerbridge Cor®: AI enabled, FDA-cleared ECG Wearable Reimagining the Future of Cardiac Care
The Cor platform’s advanced ambulatory ECG capabilities transform healthcare, enabling faster, more accurate, and affordable diagnoses that enhance patients’ quality of life.
Only patented 3 lead, 2-channel wireless AECG patch with Einthoven triangle design
Proprietary algorithm to compute derived 12 lead
Explainable AI markers for Hospital Grade Indications (under trial)
Hospital-grade diagnostics and monitoring anywhere, anytime (under trial)
Elevating Ambulatory ECGs
The Peerbridge Cor is the voice of the heart, capturing 31 rhythms with superior recording fidelity, P-wave definition, and QRS morphology.
Prevention and Intervention
Reinventing Heart Failure Detection
Early detection and treatment of heart failure can significantly improve patient outcomes and alleviate the strain on healthcare systems. Peerbridge Cor’s innovative remote monitoring solution enables timely and accurate diagnosis, even in asymptomatic individuals, presenting a more accessible and cost-effective approach than traditional methods.
Working for the Future
Home Comfort, Expert Supervision
By 2030, the predicted shortage of more than 120,000 cardiologists will significantly impact healthcare accessibility. Peerbridge Cor will be a leader in early, virtual diagnosis for patients in outpatient settings to reduce hospital stays and improve outcomes by measuring both normal and irregular beats with little disruption to a patients’ daily life.
The Cor Difference
Results in Minutes
With Peerbridge Cor, physicians can remotely monitor and deliver an accurate heart failure diagnosis within 30 minutes of applying Cor, compared to the current diagnosis timeline of 11-15 weeks with in-hospital screening tools.
The Future of Peerbridge Health:
Enabling Hospital-Grade Diagnostics and Monitoring Across the Care Continuum
Ambulatory ECG
Continuous monitoring of a patient’s heart activity while they go about their daily activities outside of a clinical setting.
Primary Care
On-demand diagnostics and screening tools with <10 minutes of wear.
Medical Research Professionals
Enabling simplified and accelerated research.
Our Blog
Lates News & Articles
Peerbridge Health today announced the beginning of enrollment for its Ejection Fraction AI-enabled Clinical Trial (EF-ACT) pivotal trial to determine Left Ventricular Ejection Fraction
Peerbridge Health, developer of a hospital-grade, remote diagnostic platform that harnesses AI to detect early signs of heart failure, today announced results of a recent feasibility trial